ArticleBMC research notes2026
Patient treatment engagement scale (PTES) for inflammatory bowel disease: exploring background factors.
Article in BMC research notes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Patient Treatment Engagement Scale (PTES) is a simplified tool for assessing patient involvement in treatment decision-making, which is an important element of patient-centered care. Shared Decision Making (SDM) is the standard measure in this field; however, it is time-consuming and often difficult for non-physician healthcare professionals to apply in routine practice. Therefore, in this study we adopted PTES as a more pragmatic alternative and exploratively analyzed factors associated with PTES scores among patients with inflammatory bowel disease (IBD).
methodsIndividual patient data were collected via a web-based questionnaire. Items potentially associated with PTES, based on previous studies, were screened, and multicollinearity was assessed using Kendall's τ. A multiple regression model was constructed using the ordinary least squares method, and standardized β values and variance inflation factor (VIF) values were calculated. Subgroup analyses were performed separately for ulcerative colitis (UC) and Crohn's disease (CD), and cross-validation was conducted.
resultsThe main factors associated with PTES scores were the number of treatment options (β = 0.191), presence of complications (β = 0.128), trust in the attending physician (β = 0.119), number of trusted healthcare professionals (β = 0.099), and availability of supportive communities (β = 0.068). The number of treatment options had a particularly strong influence on UC patients, whereas the number of trusted healthcare professionals had a greater impact on CD patients.
conclusionsProviding multiple treatment options and building trust with healthcare providers are crucial factors associated with higher PTES scores, reflecting greater patient engagement in treatment decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.